FDA inspection
Irenda Corporation: FDA inspection ending Apr 29, 2010
FDA inspection 659160 · Voluntary Action Indicated (VAI) · Los Angeles, CA
Key facts
| Inspection ID | 659160 |
|---|---|
| Firm | Irenda Corporation |
| FEI number | 2050154 |
| Address | 14131 Avalon Blvd |
| City | Los Angeles |
| State | CA |
| ZIP | 90061 |
| Country | United States |
| Fiscal year | 2010 |
| Inspection end date | Apr 29, 2010 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data